Risk of Pneumonitis with the Use of Different Immune Checkpoint Inhibitors in a Mexican Population

Conclusion: The incidence of pneumonitis secondary to treatment with PD-1 inhibitors in our Mexican population was 15%, which is 5 times higher than that found in other studies. No risk factor was identified for this increased incidence of drug-induced pneumonitis following the use of PD-1 inhibitors.Oncology

Source: Oncology - March 14, 2019 Category: Cancer & Oncology Source Type: research